Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Snowflake
SNOW
|
+$199M |
| 2 |
Amazon
AMZN
|
+$162M |
| 3 |
Analog Devices
ADI
|
+$104M |
| 4 |
Palantir
PLTR
|
+$94.3M |
| 5 |
Tesla
TSLA
|
+$82.7M |
Top Sells
| 1 |
Apple
AAPL
|
+$350M |
| 2 |
Microsoft
MSFT
|
+$261M |
| 3 |
L3Harris
LHX
|
+$185M |
| 4 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
+$166M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$135M |
Sector Composition
| 1 | Technology | 27.74% |
| 2 | Healthcare | 14.18% |
| 3 | Consumer Discretionary | 13.57% |
| 4 | Communication Services | 11.55% |
| 5 | Industrials | 8.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Tennant Co
TNC
$1.54B
| $3.04M | ﹤0.01% |
41,100
+300
| +0.7% | +$22.2K |
|
1777
Zentalis Pharmaceuticals
ZNTL
$113M
| $3.04M | ﹤0.01% |
45,600
+800
| +2% | +$53.3K |
|
|
GOGL
1778
DELISTED
Golden Ocean Group
GOGL
| $3.04M | ﹤0.01% |
287,924
| – | – |
|
1779
Columbus McKinnon
CMCO
$428M
| $3.03M | ﹤0.01% |
62,611
+1,500
| +2% | +$72.5K |
|
1780
Montrose Environmental
MEG
$1.06B
| $3.02M | ﹤0.01% |
48,900
+1,700
| +4% | +$105K |
|
|
SCR
1781
DELISTED
Score Media and Gaming Inc. Class A Subordinate Voting Shares
SCR
| $3.01M | ﹤0.01% |
88,300
+51,600
| +141% | +$1.76M |
|
|
TRIL
1782
DELISTED
Trillium Therapeutics Inc.
TRIL
| $3.01M | ﹤0.01% |
172,190
+4,400
| +3% | +$76.9K |
|
|
ACB
1783
Aurora Cannabis
ACB
$277M
| $3.01M | ﹤0.01% |
43,667
| – | – |
|
1784
St. Joe Company
JOE
$3.05B
| $3.01M | ﹤0.01% |
71,400
| – | – |
|
1785
Jamf
JAMF
$1.4B
| $3M | ﹤0.01% |
77,800
| – | – |
|
1786
Arcus Biosciences
RCUS
$1.22B
| $3M | ﹤0.01% |
85,896
| – | – |
|
|
ACCD
1787
DELISTED
Accolade, Inc. Common Stock
ACCD
| $2.99M | ﹤0.01% |
71,000
| – | – |
|
1788
Establishment Labs
ESTA
$1.1B
| $2.99M | ﹤0.01% |
41,800
| – | – |
|
1789
Cognyte Software
CGNT
$636M
| $2.99M | ﹤0.01% |
145,500
| – | – |
|
1790
e.l.f. Beauty
ELF
$7.83B
| $2.98M | ﹤0.01% |
102,700
+1,000
| +1% | +$29K |
|
1791
Cal-Maine
CALM
$5.38B
| $2.98M | ﹤0.01% |
82,400
| – | – |
|
1792
Eventbrite
EB
$265M
| $2.97M | ﹤0.01% |
157,200
+14,200
| +10% | +$269K |
|
1793
Codexis
CDXS
$220M
| $2.97M | ﹤0.01% |
127,700
| – | – |
|
1794
Regenxbio
RGNX
$479M
| $2.96M | ﹤0.01% |
70,500
+600
| +0.9% | +$25.1K |
|
1795
Enviri
NVRI
$987M
| $2.95M | ﹤0.01% |
174,000
| – | – |
|
1796
Castle Biosciences
CSTL
$660M
| $2.95M | ﹤0.01% |
44,300
+600
| +1% | +$39.9K |
|
1797
AZZ Inc
AZZ
$3.59B
| $2.94M | ﹤0.01% |
55,300
-600
| -1% | -$31.9K |
|
|
VRTV
1798
DELISTED
VERITIV CORPORATION
VRTV
| $2.94M | ﹤0.01% |
32,800
-600
| -2% | -$53.7K |
|
1799
Oceaneering
OII
$2.48B
| $2.94M | ﹤0.01% |
220,348
+1,500
| +0.7% | +$20K |
|
1800
OptimizeRx
OPRX
$350M
| $2.93M | ﹤0.01% |
34,300
+1,500
| +5% | +$128K |
|